<code id='CFF31BAC41'></code><style id='CFF31BAC41'></style>
    • <acronym id='CFF31BAC41'></acronym>
      <center id='CFF31BAC41'><center id='CFF31BAC41'><tfoot id='CFF31BAC41'></tfoot></center><abbr id='CFF31BAC41'><dir id='CFF31BAC41'><tfoot id='CFF31BAC41'></tfoot><noframes id='CFF31BAC41'>

    • <optgroup id='CFF31BAC41'><strike id='CFF31BAC41'><sup id='CFF31BAC41'></sup></strike><code id='CFF31BAC41'></code></optgroup>
        1. <b id='CFF31BAC41'><label id='CFF31BAC41'><select id='CFF31BAC41'><dt id='CFF31BAC41'><span id='CFF31BAC41'></span></dt></select></label></b><u id='CFF31BAC41'></u>
          <i id='CFF31BAC41'><strike id='CFF31BAC41'><tt id='CFF31BAC41'><pre id='CFF31BAC41'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:explore    Page View:1511
          Cigna Healthcare's logo on a phone
          Adobe

          CVS Health viewed Amy Bricker as a potential CEO. But she won’t be going to the health care conglomerate anytime soon.

          A federal appeals court has ruled Bricker, a former high-ranking executive at Cigna, cannot jump to CVS because it would violate her noncompete agreement that she signed while at Cigna. The appeals court’s decision backs up what a district court had previously ruled.

          advertisement

          The case is a prominent example of why the health care industry, and corporate America writ large, does not want noncompetes to go away. In April, the Federal Trade Commission approved a nationwide ban on most such agreements, which prevent workers from moving to other jobs, but companies and corporate lobbying groups have already sued to squash the ban.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          Synthetic human embryos? Researchers say term is overblown
          Synthetic human embryos? Researchers say term is overblown

          Amouseembryomodelcreatedentirelyfromstemcells.Scientistshavesinceusedsimilarsystemstobuildmodelsofhu

          read more
          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more

          Readout LOUD podcast: How biotech is using artificial intelligence

          HasAIreallysolvedbiology?Whatcanmachinesteachusaboutmedicine?Andwhat’sadigitaltwin?Wecoverallthatand